Preventing degenerative brain diseases: A new research centre

We have awarded £1.5m for the creation of a centre that will undertake potentially revolutionary new research into Parkinson’s disease, multiple sclerosis, and dementia.

We’re dedicated to

Identifying people at risk of developing certain degenerative brain diseases - dementia, Parkinson’s disease, and multiple sclerosis - and investigating if their onset can be prevented using simple treatments, such as aspirin.

The difference we’re making

Awarding £1.5m to support the early stages of the research project
Enabling large-scale trials to study people most at risk and investigate whether preventative treatments work 
Facilitating research with potential global health significance, which could help hundreds of thousands of people age more healthily
Potentially easing the strain on the NHS by reducing the number of patients with degenerative neurological diseases
See how you can make a difference too

The researchers 

The Wolfson Institute, led by Professor Jack Cuzick, is a world leader in clinical trials of preventive treatments for cancer and other conditions.

Professor Cuzick received a CBE for his services to breast cancer research and is applying the same methodology to these degenerative neurological diseases, partnering with leading neurologist Professor Gavin Giovannoni.

“Brain diseases such as dementia are among the greatest public health challenges of the 21st century. By spotting them early, we may be able to prevent or delay them – and help people age more healthily”. - Professor Cuzick CBE

Giving 100%

Dementia is now the leading cause of death in the UK. The socioeconomic burden of this and other major neurodegenerative diseases cannot be understated.
By the time the disease presents itself, irreversible damage has already been done. Early identification of individuals at risk is therefore critical in order to prevent the worst effects of the diseases.

 

100% of your gift goes to extraordinary projects like this.

More like this